SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001213900-24-075669 from Lianhe Sowell International Group Ltd (LHSW)

Lianhe Sowell International Group Ltd
Date: Sept. 4, 2024 · CIK: 0002004024 · Accession: 0001213900-24-075669

AI Filing Summary & Sentiment

File numbers found in text: 333-279303

Referenced dates: June 6, 2024

Date
September 4, 2024
Author
/s/ Yue Zhu
Form
CORRESP
Company
Lianhe Sowell International Group Ltd

Letter

VIA EDGAR Division of Corporation Finance Office of Technology Attention: Kathleen Collins Re: Lianhe Sowell International Group Ltd Registration Statement on Form F-1 Filed May 10, 2024 File No. 333-279303

Dear Ms. Collins:

Lianhe Sowell International Group Ltd. (“we” or the “Company”) hereby provides responses to the comments of the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”) contained in the letter dated June 6, 2024 (the “Letter”) regarding the Company’s registration statement on Form F-1 referenced above (the “Registration Statement”). Contemporaneously, the Company is submitting Amendment No. 1 to the Registration Statement (“Amendment No. 1”) via Edgar.

The Staff’s comments are repeated thereafter in bold and are followed by the Company’s responses. Page references in the text of this response letter correspond to the page numbers of Amendment No. 1. Capitalized terms used but not defined herein are used herein as defined in Amendment No. 1.

Form F-1 filed May 10, 2024

General

1. We note the changes you made to your disclosure appearing on the cover page, Prospectus Summary and Risk Factor sections relating to legal and operational risks associated with operating in China and PRC regulations. It is unclear to us that there have been changes in the regulatory environment in the PRC since your last submission on February 29, 2024 warranting revised disclosure to mitigate the challenges you face and related disclosures. The Sample Letters to China-Based Companies sought specific disclosure relating to the risk that the PRC government may intervene in or influence your operations at any time, or may exert control over operations of your business, which could result in a material change in your operations and/or the value of the securities you are registering for sale. The Sample Letters also sought specific disclosures relating to uncertainties regarding the enforcement of laws and that the rules and regulations in China can change quickly with little advance notice. Your revised disclosure in response to prior comment 3 that PRC laws and regulations can be “revised, adjusted or refined with detailed rules” does not appear to convey the same risk. Please revise your disclosure.

Response: In response to the Staff’s comment, we revised in the Amendment No.1 on the cover page, Prospectus Summary, Risk Factors, and other sections throughout the prospectus as applicable.

Division of Corporation Finance

Office of Technology

U.S. Securities & Exchange Commission

September 4, 2024

Page 2

2. Please update your financial statements for the year ended March 31, 2024, or file an exhibit to the registration statement making the necessary representations as to why such update is not necessary. Refer to Item 8.A.4 of Form 20-F and Instructions thereto.

Response: In response to the Staff’s comment, we have updated in Amendment No.1 to include financial statements for the year ended March 31, 2024.

Risk Factors

Our business may be exposed to risks associated with an increasingly concentrated customer base., page 22

3. We note your revised disclosure and response to prior comment 4. Please revise to disclose specifically when you entered into the long-term contract with Dongguan Kangzhihui Electronics Co. Ltd. (Dongguan) and identify the specific terms in this contract (e.g., whether this contract locks in pricing, requires minimum purchase orders, etc.). Tell us whether you intend to enter into similar long-term contracts with other customers, or otherwise explain why you entered into a long-term contract with this customer only. Finally, clarify whether all revenue generated by Dongguan, which you disclose was 23.4% for the six-months ended September 30, 2023, and 17.6% for the year-ended March 31, 2023, relates to this contract.

Response: We respectfully advise the Staff that we currently do not enter into any long-term framework agreement with our customers, except for the long-term framework agreements with Dongguan Kangzhihui Electronics Co., Ltd. (“Kangzhihui”) and Shenzhen Zhongnan High-tech Co., Ltd. (“Zhongnan”). As discussed in the Amendment No.1, the agreement with Kangzhihui contains substantially similar provisions as our standard sales agreement typically entered into for each specific purchase order, without special terms such as price-lock or minimum purchase orders, but with a longer term to cover product sales from November 2022 to November 2024. As disclosed in the Amendment No.1, for all customers to whom we provide machine vision solutions, we enter into standard sales agreement for each of specific purchase order. We entered into long-term agreement with Kangzhihui and Zhongnan based on the following considerations: (i) they are both among our top customers in the past fiscal year; (ii) they are both prominent electric devices manufacturers with high growth potential to order large number of devices in the future; and (iii) long-term collaboration with prominent manufacturers such as Kangzhihui and Zhongnan ensure the Company’s ability to provide high-caliber after-sale maintenance service to our important customers, which is crucial for us to capture market demand to further improve our products. Going forward, we may enter into long-term agreement with other customers based on demand of our customers and our assessment of the importance of each of our customers. We confirm that for the years ended March 31, 2024 and 2023, all revenue generated by Kangzhihui and Zhongnan relate to their respective long-term framework agreements. In response to the Staff’s comment, we also revised in the Amendment No.1 on page 21 and 97.

Risks Related to Doing Business in China, page 38

4. We note that you have removed references to China in this risk factor and removed the statement that “Intellectual Property rights and confidentiality protections in China may not be as effective as in the US.” Please explain to us the basis for making these revisions.

Response: In response to the Staff’s comment, we revised in the Amendment No.1 on page 37.

Capitalization, page 62

5. Please revise to reflect both your capitalization and indebtedness for each scenario presented. Refer to guidance in Item 3.B of Form 20-F.

Response: In response to the Staff’s comment, we revised in the Amendment No.1 on page 61.

Management’s Discussion and Analysis of Financial Condition and Results of Operations, page 65

6. We note one of your growth strategies is to strengthen your marketing and sales network to serve an expanding customer base in China. Please tell us whether you track the number of customers and consider this to be a key performance indicator. We also note your discussion of long-term cooperative relationships. Tell us the number of repeat customers for each period presented and your consideration to disclose such information. Additionally, tell us whether management uses any other key performance indicators or metrics in evaluating your business and if so, revise to include both a qualitative and quantitative discussion of any such metrics. Refer SEC Release No. 33-10751.

Response: In response to the Staff’s comment, we revised in the Amendment No.1 on page 66.

Division of Corporation Finance

Office of Technology

U.S. Securities & Exchange Commission

September 4, 2024

Page 3

Critical Accounting Policies and Estimates, page 75

7. Your revised disclosures in response to prior comment 5 appear to be a repetition of certain of your significant accounting policies as disclosed in Note 2 to your financial statements. Please revise here to address the material implications of the uncertainties that are associated with the methods, assumptions and estimates underlying your critical accounting estimates. Your expanded disclosure should address the risk related to using different assumptions and analyze their sensitivity to change based on outcomes that are deemed reasonably likely to occur. Refer to Item 5.E of Form 20-F.

Response: In response to the Staff’s comment, we revised in the Amendment No.1 on page 70.

We appreciate the assistance the Staff has provided with its comments. If you have any questions, please do not hesitate to call our counsel, Anna J. Wang, Esq. of Robinson & Cole LLP, at (212) 451-2942.

Very truly yours,
By:
/s/ Yue Zhu

Show Raw Text
CORRESP
1
filename1.htm

Lianhe Sowell International Group Ltd

Shenzhen Integrated Circuit Design Application
Industry Park

Unit 505-3, Chaguang Road No. 1089

Nanshan District, Shenzhen, China

September 4, 2024

VIA EDGAR

Division of Corporation Finance

Office of Technology

U.S. Securities & Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Attention: Kathleen Collins

    Re:
    Lianhe Sowell International Group Ltd

Registration Statement on Form F-1

Filed May 10, 2024

File No. 333-279303

Dear Ms. Collins:

Lianhe Sowell International
Group Ltd. (“we” or the “Company”) hereby provides responses to the comments of the staff (the “Staff”)
of the Securities and Exchange Commission (the “Commission”) contained in the letter dated June 6, 2024 (the “Letter”)
regarding the Company’s registration statement on Form F-1 referenced above (the “Registration Statement”). Contemporaneously,
the Company is submitting Amendment No. 1 to the Registration Statement (“Amendment No. 1”) via Edgar.

The Staff’s comments
are repeated thereafter in bold and are followed by the Company’s responses. Page references in the text of this response letter
correspond to the page numbers of Amendment No. 1. Capitalized terms used but not defined herein are used herein as defined in Amendment
No. 1.

Form F-1 filed May 10, 2024

General

 1. We note the changes you made to your disclosure appearing on the cover
                                            page, Prospectus Summary and Risk Factor sections relating to legal and operational risks
                                            associated with operating in China and PRC regulations. It is unclear to us that there have
                                            been changes in the regulatory environment in the PRC since your last submission on February
                                            29, 2024 warranting revised disclosure to mitigate the challenges you face and related disclosures.
                                            The Sample Letters to China-Based Companies sought specific disclosure relating to the risk
                                            that the PRC government may intervene in or influence your operations at any time, or may
                                            exert control over operations of your business, which could result in a material change in
                                            your operations and/or the value of the securities you are registering for sale. The Sample
                                            Letters also sought specific disclosures relating to uncertainties regarding the enforcement
                                            of laws and that the rules and regulations in China can change quickly with little advance
                                            notice. Your revised disclosure in response to prior comment 3 that PRC laws and regulations
                                            can be “revised, adjusted or refined with detailed rules” does not appear to
                                            convey the same risk. Please revise your disclosure.

Response: In response to the Staff’s
comment, we revised in the Amendment No.1 on the cover page, Prospectus Summary, Risk Factors, and other sections
throughout the prospectus as applicable.

Division of Corporation Finance

Office of Technology

U.S. Securities & Exchange Commission

September 4, 2024

Page 2

 2. Please update your financial statements for
                                            the year ended March 31, 2024, or file an exhibit to the registration statement making the
                                            necessary representations as to why such update is not necessary. Refer to Item 8.A.4 of
                                            Form 20-F and Instructions thereto.

Response: In response to the Staff’s
comment, we have updated in Amendment No.1 to include financial statements for the year ended March 31, 2024.

Risk Factors

Our business may be exposed to
risks associated with an increasingly concentrated customer base., page 22

 3. We note your revised disclosure and response to prior comment 4. Please
                                            revise to disclose specifically when you entered into the long-term contract with Dongguan
                                            Kangzhihui Electronics Co. Ltd. (Dongguan) and identify the specific terms in this contract
                                            (e.g., whether this contract locks in pricing, requires minimum purchase orders, etc.).
                                            Tell us whether you intend to enter into similar long-term contracts with other customers,
                                            or otherwise explain why you entered into a long-term contract with this customer only. Finally,
                                            clarify whether all revenue generated by Dongguan, which you disclose was 23.4% for the six-months
                                            ended September 30, 2023, and 17.6% for the year-ended March 31, 2023, relates to this contract.

Response:  We respectfully advise the Staff that we currently do not enter into any long-term framework agreement with our customers, except for
the long-term framework agreements with Dongguan Kangzhihui Electronics Co., Ltd. (“Kangzhihui”) and Shenzhen Zhongnan High-tech
Co., Ltd. (“Zhongnan”). As discussed in the Amendment No.1, the agreement with Kangzhihui contains substantially similar provisions
as our standard sales agreement typically entered into for each specific purchase order, without special terms such as price-lock or minimum
purchase orders, but with a longer term to cover product sales from November 2022 to November 2024. As disclosed in the Amendment No.1,
for all customers to whom we provide machine vision solutions, we enter into standard sales agreement for each of specific purchase order.
We entered into long-term agreement with Kangzhihui and Zhongnan based on the following considerations: (i) they are both among our top
customers in the past fiscal year; (ii) they are both prominent electric devices manufacturers with high growth potential to order large
number of devices in the future; and (iii) long-term collaboration with prominent manufacturers such as Kangzhihui and Zhongnan ensure
the Company’s ability to provide high-caliber after-sale maintenance service to our important customers, which is crucial for us
to capture market demand to further improve our products. Going forward, we may enter into long-term agreement with other customers based
on demand of our customers and our assessment of the importance of each of our customers. We confirm that for the years ended March 31, 2024 and 2023, all revenue generated by Kangzhihui and Zhongnan relate to their respective
long-term framework agreements. In response to the Staff’s
comment, we also revised in the Amendment No.1 on page 21 and 97.

Risks Related to Doing Business
in China, page 38

 4. We note that you have removed references to China in this risk factor
                                            and removed the statement that “Intellectual Property rights and confidentiality protections
                                            in China may not be as effective as in the US.” Please explain to us the basis for
                                            making these revisions.

Response: In response to the Staff’s
comment, we revised in the Amendment No.1 on page 37.

Capitalization, page 62

 5. Please revise to reflect
                                            both your capitalization and indebtedness for each scenario presented. Refer to guidance
                                            in Item 3.B of Form 20-F.

Response: In response to the Staff’s
comment, we revised in the Amendment No.1 on page 61.

Management’s Discussion
and Analysis of Financial Condition and Results of Operations, page 65

 6. We note one of your growth
                                            strategies is to strengthen your marketing and sales network to serve an expanding customer
                                            base in China. Please tell us whether you track the number of customers and consider this
                                            to be a key performance indicator. We also note your discussion of long-term cooperative
                                            relationships. Tell us the number of repeat customers for each period presented and your
                                            consideration to disclose such information. Additionally, tell us whether management uses
                                            any other key performance indicators or metrics in evaluating your business and if so, revise
                                            to include both a qualitative and quantitative discussion of any such metrics. Refer SEC
                                            Release No. 33-10751.

Response: In response to the Staff’s
comment, we revised in the Amendment No.1 on page 66.

Division of Corporation Finance

Office of Technology

U.S. Securities & Exchange Commission

September 4, 2024

Page 3

Critical Accounting Policies
and Estimates, page 75

 7. Your revised disclosures
                                            in response to prior comment 5 appear to be a repetition of certain of your significant accounting
                                            policies as disclosed in Note 2 to your financial statements. Please revise here to address
                                            the material implications of the uncertainties that are associated with the methods, assumptions
                                            and estimates underlying your critical accounting estimates. Your expanded disclosure should
                                            address the risk related to using different assumptions and analyze their sensitivity to
                                            change based on outcomes that are deemed reasonably likely to occur. Refer to Item 5.E of
                                            Form 20-F.

Response: In response to the Staff’s
comment, we revised in the Amendment No.1 on page 70.

We appreciate the assistance
the Staff has provided with its comments. If you have any questions, please do not hesitate to call our counsel, Anna J. Wang, Esq. of
Robinson & Cole LLP, at (212) 451-2942.

    Very truly yours,

    By:
    /s/ Yue Zhu

    Yue Zhu

    cc:
    Anna J. Wang, Esq.